Updated:
108 Biocapital Growth Fund, LP
108 BioCapital Growth Fund, LP is an exempt reporting adviser in Danbury, CT. It advises the 108 BioCapital Growth Fund, LP. The fund focuses on life sciences...
108 Biocapital Growth Fund, LP
108 BioCapital Growth Fund, LP is an exempt reporting adviser in Danbury, CT. It advises the 108 BioCapital Growth Fund, LP. The fund focuses on life sciences and healthcare investments.
General information
Firm type
Venture Capital Growth Fund
Year founded
2020
Location
Region
North America
Country
United States
City
Danbury
Corporate office
San Francisco, CA, United States
Sector focus
Frequently asked questions
What therapeutic areas does 108 Biocapital Growth Fund prioritize?
The fund invests across multiple therapeutic areas including oncology, neurology, and rare diseases. It backs companies developing small molecules, biologics, and cell/gene therapies.
How does 108 Biocapital Growth Fund source its deal flow?
The fund sources deals through relationships with research institutions, licensing partners, and co-investment relationships with larger life sciences venture firms. Public disclosures are limited.
What is 108 Biocapital Growth Fund's geographic focus?
The fund concentrates on North America, primarily the United States. Its portfolio companies are largely located in major biotech hubs including the San Francisco Bay Area, Boston, and San Diego.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: